Cargando…

Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth

Detalles Bibliográficos
Autores principales:	Deronic, Adnan, Tahvili, Sahar, Leanderson, Tomas, Ivars, Fredrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976468/ https://www.ncbi.nlm.nih.gov/pubmed/27502070 http://dx.doi.org/10.1186/s12885-016-2649-7

Ejemplares similares

The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth
por: Deronic, Adnan, et al.
Publicado: (2016)

Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment
por: Olsson, Anders, et al.
Publicado: (2015)

Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
por: Olsson, Anders, et al.
Publicado: (2010)

CD11b(+)Ly6C(++)Ly6G(-) cells show distinct function in mice with chronic inflammation or tumor burden
por: Källberg, Eva, et al.
Publicado: (2012)

The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis
por: Fransén Pettersson, Nina, et al.
Publicado: (2018)

Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse
por: Tahvili, Sahar, et al.
Publicado: (2018)

Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment
por: Isaacs, John T., et al.
Publicado: (2014)

S100A9 and tumor growth
por: Leanderson, Tomas, et al.
Publicado: (2012)

Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
por: Björk, Per, et al.
Publicado: (2009)

Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer
por: Nakhlé, Jessica, et al.
Publicado: (2016)

Mechanisms of action of tasquinimod on the tumour microenvironment
por: Raymond, E., et al.
Publicado: (2013)

N-(Quinolin-8-yl)quinoline-2-carboxamide
por: Li, Yanfeng, et al.
Publicado: (2012)

Preventing tumor progression to the bone by induced tumor-suppressing MSCs: Erratum
por: Sun, Xun, et al.
Publicado: (2022)

Erratum to: Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences
por: Amano, Jun, et al.
Publicado: (2013)

A review of tasquinimod in the treatment of advanced prostate cancer
por: Williamson, Stuart Charles, et al.
Publicado: (2013)

Erratum: Odontogenic tumor: Indian scenario
Publicado: (2017)

Erratum: Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2019)

S100A9 Interaction with TLR4 Promotes Tumor Growth
por: Källberg, Eva, et al.
Publicado: (2012)

Erratum: Congenital Malignant Rhabdoid Tumor of Neck
Publicado: (2023)

Erratum to “Uterine Tumor Resembling Ovarian Sex Cord Tumors Type II with Vaginal Vault Recurrence”
por: Marrucci, Oriana, et al.
Publicado: (2020)

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
por: Fan, Rong, et al.
Publicado: (2023)

Erratum: Tumor Invasion Optimization by Mesenchymal-Amoeboid Heterogeneity
por: Hecht, Inbal, et al.
Publicado: (2015)

Lipoxin-Induced Phenotypic Changes in CD115(+)LY6C(hi) Monocytes TAM Precursors Inhibits Tumor Development
por: de-Brito, Natália Mesquita, et al.
Publicado: (2019)

Erratum to: Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors
por: Park, Younghee, et al.
Publicado: (2017)

Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer
por: Gupta, Neha, et al.
Publicado: (2014)

Erratum to: ‘Hedgehog signaling: modulation of cancer properties and tumor microenvironment’
por: Hanna, Ann, et al.
Publicado: (2016)

Erratum to: RIZ1: a potential tumor suppressor in glioma
por: Zhang, Chenran, et al.
Publicado: (2016)

Erratum to: The effect of soluble E-selectin on tumor progression and metastasis
por: Kang, Shin-Ae, et al.
Publicado: (2016)

Erratum: Kasabach-Merritt syndrome with large cutaneous vascular tumors
Publicado: (2020)

Erratum: Navigated multiplanar osteotomies for spinal primary bone tumors
Publicado: (2022)

Ly phenotype of cytotoxic T cells for syngeneic tumor
Publicado: (1976)

Erratum: Quantitative assessment of tumor-associated tissue eosinophilia and mast cells in tumor proper and lymph nodes of oral squamous cell carcinoma
Publicado: (2018)

N-(Quinolin-8-yl)ferrocene-1-carboxamide
por: Li, Xia, et al.
Publicado: (2011)

Crystal structure of benzo[h]quinoline-3-carboxamide
por: Grathwol, Christoph W., et al.
Publicado: (2019)

Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion: Erratum
Publicado: (2015)

A case report of phosphaturic mesenchymal tumor-induced osteomalacia: Erratum
Publicado: (2018)

A gastrointestinal stromal tumor with acute bleeding: Management and nursing: Erratum
Publicado: (2018)

Tumor Theranostics of Transition Metal Ions Loaded Polyaminopyrrole Nanoparticles: Erratum
por: Li, Shuyao, et al.
Publicado: (2022)

Erratum zu: Tophöse Gicht als Differenzialdiagnose eines präaurikulären Tumors
por: Birk, Amelie, et al.
Publicado: (2023)

Occurrences and Functions of Ly6C(hi) and Ly6C(lo) Macrophages in Health and Disease
por: Li, Yuan-hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pml457uso2qvo01231t112eo08